Aquestive (NASDAQ: AQST) insider schedules new stock sale after recent 10b5-1 trades

Rhea-AI Filing Summary

Aquestive Therapeutics insider Daniel R. Barber filed a notice of proposed sales of 25,000 shares of common stock of AQST, with an aggregate market value of $106,250.00, expected on August 17, 2026. The shares relate to Restricted Stock Units originally dated March 9, 2026. The filing also lists prior 10b5-1 plan sales of AQST common stock during the past three months.

Key Figures

Proposed shares to be sold: 25,000 shares Proposed aggregate market value: $106,250.00 10b5-1 sale June 15, 2026: 25,000 shares for $104,010.00 +3 more

6 metrics

Proposed shares to be sold 25,000 shares Common stock proposed for sale with market value disclosure

Proposed aggregate market value $106,250.00 Aggregate market value of 25,000 common shares planned for sale

10b5-1 sale June 15, 2026 25,000 shares for $104,010.00 Common stock sold under 10b5-1 plan on 06/15/2026

10b5-1 sale July 15, 2026 4,631 shares for $18,683.50 Common stock sold under 10b5-1 plan on 07/15/2026

10b5-1 sale July 16, 2026 20,369 shares for $81,508.59 Common stock sold under 10b5-1 plan on 07/16/2026

RSU-related shares 25,000 shares Common shares associated with Restricted Stock Units dated 03/09/2026

Key Terms

Restricted Stock Units, 10b5-1 Sales, Form 144

3 terms

Restricted Stock Units financial

"Common | 03/09/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for DANIEL R BARBER 30 Technology Drive"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What share sale is disclosed for AQST in this Form 144 filing?

The filing discloses a proposed sale of 25,000 shares of AQST common stock with an aggregate market value of $106,250.00, expected to occur on August 17, 2026, related to previously granted Restricted Stock Units.

What prior 10b5-1 sales of AQST shares did Daniel R. Barber report?

Daniel R. Barber reported 10b5-1 sales of AQST common stock of 25,000 shares for $104,010.00 on June 15, 2026, 4,631 shares for $18,683.50 on July 15, 2026, and 20,369 shares for $81,508.59 on July 16, 2026.

What is the aggregate market value of the AQST shares proposed to be sold?

The aggregate market value of the 25,000 AQST shares proposed to be sold is $106,250.00. This value is associated with the common stock planned for sale on August 17, 2026, as stated in the notice.

How many AQST shares linked to Restricted Stock Units are referenced in the filing?

The filing references 25,000 AQST common shares tied to Restricted Stock Units dated March 9, 2026. These units are associated with the proposed sale described in the notice of intention to sell securities.

On which market is the AQST common stock indicated as traded in this notice?

The notice indicates that the AQST common stock involved in the proposed sale is traded on NASDAQ. This identifies the market venue for the securities referenced in the planned and prior sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:35 PM Accepted by SEC EDGAR 08/17/2026 - 04:34 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	106250.00	125511648	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/09/2026	Restricted Stock Units	Issuer			25000	03/09/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL R BARBER 30 Technology Drive Warren NJ 07059	Common	07/16/2026	20369	81508.59
10b5-1 Sales for DANIEL R BARBER 30 Technology Drive Warren NJ 07059	Common	07/15/2026	4631	18683.50
10b5-1 Sales for DANIEL R BARBER 30 Technology Drive Warren NJ 07059	Common	06/15/2026	25000	104010.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)